<VariationArchive VariationID="8377" VariationName="GDF5, 22-BP DUP" VariationType="Duplication" Accession="VCV000008377" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2015-10-05" MostRecentSubmission="2024-07-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="23416" VariationID="8377">
      <GeneList>
        <Gene Symbol="GDF5" FullName="growth differentiation factor 5" GeneID="8200" HGNC_ID="HGNC:4220" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>20q11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="35433347" stop="35454749" display_start="35433347" display_stop="35454749" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="34021148" stop="34026026" display_start="34021148" display_stop="34026026" Strand="-" />
          </Location>
          <OMIM>601146</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GDF5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GDF5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>GDF5, 22-BP DUP</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20q11.2</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>22-BP DUP</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="601146.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GDF5, 22-BP DUP AND Acromesomelic dysplasia 2C, Hunter-Thompson type" Accession="RCV000008883" Version="6">
        <ClassifiedConditionList TraitSetID="2302">
          <ClassifiedCondition DB="MedGen" ID="C2930970">Acromesomelic dysplasia 2C, Hunter-Thompson type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1996-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1996-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-10-05" MostRecentSubmission="2024-07-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2703235</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8589725</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2302" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="125" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Acromesomelic dysplasia 2C, Hunter-Thompson type</ElementValue>
                <XRef ID="MONDO:0008717" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acromesomelic dwarfism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acromesomelic dysplasia, Hunter-Thompson type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AMD2C</ElementValue>
                <XRef Type="MIM" ID="201250" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="506" />
                <XRef ID="506" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="968" DB="Orphanet" />
              <XRef ID="C2930970" DB="MedGen" />
              <XRef ID="MONDO:0008717" DB="MONDO" />
              <XRef Type="MIM" ID="201250" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29093" SubmissionDate="2020-04-03" DateLastUpdated="2024-07-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601146.0001_ACROMESOMELIC DYSPLASIA 2C (1 family)" title="GDF5, 22-BP DUP_ACROMESOMELIC DYSPLASIA 2C (1 family)" />
        <ClinVarAccession Accession="SCV000029093" DateUpdated="2024-07-07" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1996-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamilies="1" />
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family described by Langer et al. (1989) from the Choco District of Colombia affected with the Hunter-Thompson type of chondrodysplasia (AMD2C; 201250), Thomas et al. (1996) demonstrated that affected members were homozygous for a 22-bp tandem duplication frameshift mutation in the mature region of the CDMP1 protein. Hunter-Thompson-type chondrodysplasia and mouse 'bp' are typified by abnormalities restricted to the limbs and the severity of the long bone shortening progresses in a proximal to distal direction. The hands and feet are most severely affected but the distal phalanges are relatively normal.</Attribute>
              <Citation>
                <ID Source="PubMed">2703235</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8589725</ID>
              </Citation>
              <XRef DB="OMIM" ID="201250" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GDF5" />
          </GeneList>
          <Name>GDF5, 22-BP DUP</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">22-BP DUP</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601146.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ACROMESOMELIC DYSPLASIA 2C (1 family)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

